IFPMA Interview: Antimicrobial Resistance, Regulatory Systems High On Pharma Industry 2016 Agenda

Priorities for the pharmaceutical industry in 2016 are antimicrobial resistance and the quest for new antibiotics, the strengthening of regulatory systems to facilitate access to drugs, and work on non-communicable diseases, such as diabetes and cancer, according to the head of an international pharmaceutical industry group.








